Literature DB >> 19108950

SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells.

Yu Zhang1, Shuyan Huang, Wei Dong, Lin Li, Yunpeng Feng, Lina Pan, Zhenkun Han, Xiuli Wang, Guoling Ren, Dongmei Su, Baiqu Huang, Jun Lu.   

Abstract

The sex-determining region Y-box 7 (Sox7) is a member of high mobility group (HMG) transcription factor family, essential for embryonic development and endoderm differentiation. Deregulation of Wnt signaling pathway is a hallmark of colorectal cancer. Our results showed that the expression level of SOX7 was frequently down-regulated in human colorectal cancer cell lines and in primary colorectal tumor tissues, and the SOX7 silencing was partially due to the aberrant DNA methylation of the gene. Restoration of SOX7 induced colorectal cancer cell apoptosis, inhibited cell proliferation and colony formation. In addition, SOX7 efficiently suppressed beta-catenin-mediated transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108950     DOI: 10.1016/j.canlet.2008.11.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.

Authors:  Bing Li; Zhiping Ge; Shipeng Song; Shengbin Zhang; Hong Yan; Boyun Huang; Yangde Zhang
Journal:  Pathol Oncol Res       Date:  2012-07-10       Impact factor: 3.201

2.  The regulation of SOX7 and its tumor suppressive role in breast cancer.

Authors:  Daniel B Stovall; Meimei Wan; Lance D Miller; Paul Cao; Dejan Maglic; Qiang Zhang; Martha R Stampfer; Wennuan Liu; Jianfeng Xu; Guangchao Sui
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

3.  Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.

Authors:  Yongzheng Bao; Bin Chen; Qiang Wu; Konghe Hu; Xinhua Xi; Wengang Zhu; Xueren Zhong; Jianting Chen
Journal:  Clin Exp Med       Date:  2015-10-29       Impact factor: 3.984

4.  Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.

Authors:  Yi-Wen Huang; Jingqin Luo; Yu-I Weng; David G Mutch; Paul J Goodfellow; David S Miller; Tim H-M Huang
Journal:  Gynecol Oncol       Date:  2010-03-07       Impact factor: 5.482

5.  MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

Authors:  Fei Shen; Wen-Song Cai; Zhe Feng; Jiang-Lin Li; Ji-Wei Chen; Jie Cao; Bo Xu
Journal:  Tumour Biol       Date:  2014-11-19

6.  SOXs in human prostate cancer: implication as progression and prognosis factors.

Authors:  Wei-de Zhong; Guo-qiang Qin; Qi-shan Dai; Zhao-dong Han; Shan-ming Chen; Xiao-hui Ling; Xin Fu; Chao Cai; Jia-hong Chen; Xi-bin Chen; Zhuo-yuan Lin; Ye-han Deng; Shu-lin Wu; Hui-chan He; Chin-lee Wu
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

Review 7.  SOX7: from a developmental regulator to an emerging tumor suppressor.

Authors:  Daniel B Stovall; Paul Cao; Guangchao Sui
Journal:  Histol Histopathol       Date:  2013-11-29       Impact factor: 2.303

Review 8.  The Sox transcriptional factors: Functions during intestinal development in vertebrates.

Authors:  Liezhen Fu; Yun-Bo Shi
Journal:  Semin Cell Dev Biol       Date:  2016-08-25       Impact factor: 7.727

9.  DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences.

Authors:  Scott J Diede; Jamie Guenthoer; Linda N Geng; Sarah E Mahoney; Michael Marotta; James M Olson; Hisashi Tanaka; Stephen J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 10.  Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease.

Authors:  Jay D Kormish; Débora Sinner; Aaron M Zorn
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.